Ranbaxy

Source: www.rediff.com --- 14 days ago
The government on Wednesday announced the approval of Japan-based Daiichi Sankyo's proposed acquisition of shares in domestic pharma major Ranbaxy, along with 23 other proposals for a total FDI investment of Rs 753.14 crore ...

Source: www.rediff.com --- 16 days ago
Pursuant to the Securities and Exchange Board of India (Sebi) letter dated August 4, giving its observations on the draft letter of offer filed, the open offer would open on August 16, instead of earlier scheduled August 8, Ranbaxy Laboratories said in a filing to the Bombay Stock Exchange. ...

Source: www.rediff.com --- 12 days ago
K Raghavendra Rao, one of the founding promoters and managing director of Orchid Chemicals and Pharmaceuticals, said he may initiate talks to buy back its 14.7 per cent stake that is now with Rexcel, a unit of pharma major Ranbaxy. ...

Source: economictimes.indiatimes.com --- 14 days ago
An open offer for Ranbaxy Laboratories from Japanese drug maker Daiichi Sankyo Co will start on August 16 and close on September 4. Ranbaxy sell-off ...

Source: www.moreover.com --- 20 days ago
NEW DELHI-Ranbaxy Laboratories Ltd., India's largest pharmaceutical company, said Friday that the World Health Organization had included another of its HIV-fighting drugs on its prequalification list. ...

Source: www.moreover.com --- 18 days ago
Ranbaxy Laboratories Limited (Ranbaxy), announced today that the World Health Organisation (WHO), Geneva, has approved and included another of the Company's Anti Retrovirals (ARV) drug in its pre-qualification list. ...

Source: timesofindia.indiatimes.com --- 9 days ago
Japanese drug major Daiichi Sankyo Company Ltd will pay Rs 737 per share to shareholders of Ranbaxy Laboratories in its 20-day open offer beginning August 16. ...

Source: news.in.msn.com --- 17 days ago
...

Source: www.moneycontrol.com --- 16 days ago
Rajen Shah of Angel Broking is of the view that there is a limited downside in Ranbaxy Laboratories. At about Rs 420 levels, it would be trading at about 20times the current year’s earnings because this year expect the company to report about Rs 2021 kind of earnings. So that’s a reasonable level for the stock to trade. ...

Source: www.bloomberg.com --- 6 days ago
The Food and Drug Administration approved 18 generic drugs made by Ranbaxy Laboratories Ltd. even as the U.S. investigated whether the company fabricated data to get its medicines cleared. ...

Source: news.in.msn.com --- 16 days ago
...

Source: news.in.msn.com --- 32 days ago
...

Source: pubs.acs.org --- 32 days ago
Questions about quality spark concerns over buyout ...

Source: www.thehindu.com --- 14 days ago
...

Source: clientportal.ibb.ubs.com --- 1 day ago
This document is related to the following: Regions Global Emerging Markets Asia India Asia Pacific Asia Pacific Ex. JP Asia Emerging Sectors Global Pharmaceuticals Global Healthcare Asian Pharmaceuticals Indian Pharmaceuticals Asian Healthcare Indian Healthcare Asian Pacific Pharmaceuticals Asian Pacific Healthcare Asian Pacific Ex. JP Pharmaceuticals Asian Pacific Ex. JP Healthcare Asia Emerging Pharmaceuticals Asia Emerging Healthcare Companies RANB.BO Ranbaxy Subjects Change in Recommendation Company Update Morning Note ...

Source: www.medicalnewstoday.com --- 1 day ago
ProPublica on Thursday examined a U.S. investigation into whether Indian pharmaceutical company Ranbaxy engaged in a "pattern of systemic fraudulent conduct" by concealing its drug manufacturing process violated FDA standards, including HIV/AIDS medications used in the ...

Source: www.dnaindia.com --- 18 days ago
Daiichi Sankyo said its open offer to acquire 92.5 million shares of Rs 5 each of Ranbaxy Laboratories, representing 20 percent of its paid-up capital, might under go a change. ...

Source: feeds.business-standard.com --- 18 days ago
The United States district court of Maryland has given 60 days time to Ranbaxy to submit all documents sought by the Department of Justice through an information-seeking motion before the court on ...

Source: feeds.business-standard.com --- 16 days ago
Delay in Sebi approval prompts move.??Japanese drug major Daiichi Sankyo today deferred its proposed open offer to acquire an additional 20 per cent stake in Ranbaxy Laboratories, citing a delay in ...

Source: feeds.business-standard.com --- 13 days ago
Ranbaxy has announced a cash reward of Rs 1 lakh for the person giving information about its helicopter that went missing on August 3 evening while on way to Chhattisgarh from Hyderabad.??The ...